VA Program Now Largest Genomic Database in the World | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

VA Program Now Largest Genomic Database in the World

August 4, 2016
by David Raths
| Reprints
Million Veteran Program enrolls 500,000th U.S. veteran to study how genes affect health

An Army veteran from Montgomery, Ala., recently became the 500,000th  person to voluntarily enroll in the Department of Veterans Affairs’ Million Veteran Program (MVP), which the VA claims makes  MVP the largest genomic database in the world.

MVP is funded entirely by the VA’s Office of Research & Development. Its goal is to partner with veterans receiving their care in the VA Healthcare System to study how genes affect health.

Launched in 2011 and part of the White House Precision Medicine Initiative, MVP’s participants donate blood from which DNA is extracted. A baseline and periodic follow-up surveys track veterans’ military experiences, health and lifestyles. Researchers believe the information contained in the database could hold the key to preventing and treating diseases.

Speaking at the White House on Feb. 25, 2016, President Obama said, “Our Precision Medicine Initiative has been designed to get all these various building blocks brought together so that the whole is greater than the sum of its parts. So that, for example, the VA — which has been gathering genomic data on a large number of our men and women who have served this country in order to serve them better within the VA system — can make them connect with researchers at a particular university who are focused on a particular disease, and can we use big data to accelerate the research process much more rapidly.”

As part of the program, participating veterans grant researchers secure access to their electronic health records and agree to be contacted about participating in future research. Samples and data used are coded to protect participants’ identification and privacy, the VA said. Approximately 62 percent of MVP enrollees report a current or past diagnosis of high blood pressure and about a third report tinnitus. Also, nearly a third or 32 percent of Veterans present with a history or current diagnosis of cancer.

Last year the VA announced four studies that will use genetic and other data from MVP to answer key questions on heart disease, kidney disease, and substance use—high-priority conditions affecting veterans.

The studies, involving consortiums of VA researchers and university colleagues, are exploring specific questions related to chronic illnesses common among veterans. They are also helping establish new methods for securely linking MVP data with other sources of health information, including non-VA sources such as the Centers for Medicaid and Medicare Services.

The studies include the following:

Cardiovascular risk factors—Drs. Farooq Amin and Peter Wilson at the Atlanta VA Medical Center, and Dr. Kelly Cho at the Boston VA Health Care System are leading an effort probing the genes that influence how obesity and lipid levels affect heart risk. Using MVP data, their team is also looking at whether these genetic factors differ among African Americans and Hispanics.

Multi-substance use—Drs. Daniel Federman and Amy Justice at the VA Connecticut Healthcare System, and Dr. Henry Kranzler at the Philadelphia VA Medical Center are examining the genetic risk factors for chronic use of alcohol, tobacco, and opioids—and the dangerous use of all three together.

Pharmacogenomics of kidney disease—Dr. Adriana Hung at the VA Tennessee Valley Healthcare System is focusing on how genes affect the risk and progression of kidney disease. One goal is to examine how patients with diabetes—who often develop kidney problems—respond differently to the drug metformin, the standard first-line treatment for diabetes, based on their genetic profile. The project will also look at the genetics of hypertension, a major risk factor for kidney disease.

Metabolic conditions—Dr. Philip Tsao at the VA Palo Alto Health Care System and Dr. Kyong-Mi Chang at the Philadelphia VA Medical Center are leading a team of researchers from five VA regions and two universities exploring the role of genetics in obesity, diabetes, and abnormal lipid levels (namely, cholesterol and triglycerides), as drivers of heart disease.

 

 

 

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Boston Children's Accelerates Data-Driven Approach to Clinical Research

In an effort to bring a more data-driven approach to clinical research, Boston Children’s Hospital has joined the TriNetX global health research network.

Paper Records, Films Most Common Type of Healthcare Data Breach, Study Finds

Despite the high level of hospital adoption of electronic health records and federal incentives to do so, paper and films were the most frequent location of breached data in hospitals, according to a recent study.

AHA Appoints Senior Advisor for Cybersecurity and Risk

The American Hospital Association (AHA) has announced that John Riggi has joined the association as senior advisor for cybersecurity and risk.

Report: Healthcare Accounted for 45% of All Ransomware Attacks in 2017

Healthcare fell victim to more ransomware attacks than any other industry in 2017, according to a new report from global cybersecurity insurance company Beazley.

Study: Use of EHRs Does Not Reduce Administrative Costs

A recent study by Duke University and Harvard Business School researchers found that costs for processing a single bill ranged from $20 for a primary care visit to $215 for an inpatient surgical procedure, or up to 25 percent of revenue.

Kibbe to Step Down as CEO of DirectTrust

David Kibbe, M.D., M.B.A., announced he would step down as president and CEO of DirectTrust at the end of the year.